MASI

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Masimo Corp

Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Masimo's mission is to improve patient outcomes and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.4 Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,5 improve CCHD screening in newborns,6 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.7-10 Masimo SET® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world,11 and is the primary pulse oximetry at 9 of the top 10 hospitals according to the 2020-21 U.S. News and World Report Best Hospitals Honor Roll.12 Masimo continues to refine SET® and in 2018, announced that SpO2 accuracy on RD SET® sensors during conditions of motion has been significantly improved, providing clinicians with even greater confidence that the SpO2 values they rely on accurately reflect a patient's physiological status. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo's family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7® and Radius PPG™, portable devices like Rad-67™, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97®. Masimo hospital automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris® Gateway, iSirona™, Patient SafetyNet, Replica™, Halo ION™, UniView™, UniView :60™, and Masimo SafetyNet™.
CEO
Joe Kiani
Employees
2000
Headquarters

52 Discovery
Irvine, California 92618-3105
Phone: 19492977000
www.masimo.com

News

Masimo CEO waives right to $600 mln payout in fight with activist investor
Mar 23, 2023 15:23pm

Masimo Corp Chief Executive Joe Kiani has waived his rights for roughly $600 million in special payment if the U.S. medical device maker appoints a lead independent director, the company said on Thursday. The company, which named board member Michael Cohen as a lead independent director, said Kiani has also agreed that a move by […]


Source:Financial Post
Masimo announces changes to board amid proxy fight with Politan
Mar 23, 2023 14:28pm

Masimo Corporation (MASI) announced several changes to its board of directors on Thursday amid a proxy battle with ctivist investor Politan Capital Management. Read the full story here.


Source:Seeking Alpha
Masimo: Healthcare Data Analysis And Not Expensive (NASDAQ:MASI)
Mar 23, 2023 09:08am

Masimo Corporation is a healthcare business that intends to improve the quality of life of its customers. Read more to see why MASI stock is a Buy.


Source:Seeking Alpha
Global Mechanical Ventilator Market to Reach $3.967 Billion by 2027: Featuring GE Healthcare, Medtronic, ResMed and HEYER Medical Among Others
Mar 20, 2023 21:45pm


Source:Kwhen Finance
Masimo Corporation: Re-Rating Nearing Completion
Mar 17, 2023 22:41pm

Masimo Corporation shares fell off a cliff early in 2022 amidst the pullback in momentum names and a poorly received deal for Sound. Click here for more on MASI.


Source:Seeking Alpha
Masimo: European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring
Mar 15, 2023 07:06am

Technologies Like Masimo SpHb Offer a "Practical Approach" to Perioperative Blood Management and "Timely Detection of Changes" Masimo (NASDAQ: MASI) today announced that updated guidelines publish…


Source:Finanz Nachrichten
European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring
Mar 15, 2023 07:00am

Masimo (NASDAQ: MASI) today announced that updated guidelines published by the European Society of Anaesthesiology and Intensive Care (ESAIC) highlight the value of noninvasive, continuous hemoglobin (Hb) monitoring in helping clinicians manage perioperative bleeding. Referencing studies using technologies such as Masimo SpHb, the guidelines note that “the use of noninvasive Hb-monitoring methods


Source:Wallstreet:Online
New Study Finds That Masimo PVi Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery
Mar 09, 2023 07:00am

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Pediatrics International in which Dr. Ya-Fei Liu and colleagues at Peking University First Hospital in Beijing evaluated the ability of noninvasive, continuous Masimo PVi, alongside other dynamic parameters, to predict fluid responsiveness in children 1-3 years old who were undergoing major neurosurgery. The


Source:Wallstreet:Online
Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives
Mar 07, 2023 13:00pm

IRVINE, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Masimo and Temple Health are entering into a strategic innovation collaboration focused on hospital automation and telehealth.


Source:Business Wire
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
Mar 06, 2023 15:28pm

Researchers Found That Noninvasive, Continuous PVi Was Equally Effective in Guiding Fluid Management As Stroke Volume Variation (SVV), an Invasive Method Requiring an Arterial Line NEUCHATEL, Switzerland — Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions […]


Source:Financial Post
New Study Evaluates the Use of Masimo PVi As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
Mar 06, 2023 15:28pm

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in Bathinda and Pondicherry, India evaluated the use of noninvasive, continuous Masimo PVi, as part of goal-directed fluid therapy (GDFT), to guide intraoperative fluid administration during neurosurgery – the first study


Source:Wallstreet:Online
CalSTRS Joins Politan Capital Management in Legal Action Against Masimo CEO’s Employment Agreement
Mar 03, 2023 13:00pm

NEW YORK--(BUSINESS WIRE)--Politan Capital Management (together with its affiliates, “Politan”), a 9% stockholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) today announced that the California State Teachers’ Retirement System (CalSTRS) has joined Politan’s ongoing legal action against Masimo and its Board of Directors (the “Board”). Politan’s lawsuit, filed in the Court of Chancery of the State of Delaware, challenges the validity and legality of the employment agreement


Source:Business Wire
California teachers pension fund joins Politan''s legal fight against Masimo
Mar 03, 2023 12:14pm

The $311 billion California state teachers pension fund is teaming up with an activist investor to stop Masimo Corp''s chief from receiving over half a billion dollars if there are changes to the U.S. medical device maker''s corporate governance, including its board of directors.


Source:Reuters
California teachers pension fund joins Politan’s legal fight against Masimo
Mar 03, 2023 12:00pm

NEW YORK — The $311 billion California state teachers pension fund is teaming up with an activist investor to stop Masimo Corp’s chief from receiving over half a billion dollars if there are changes to the U.S. medical device maker’s corporate governance, including its board of directors. The California State Teachers’ Retirement System (CalSTRS) told […]


Source:Financial Post
Masimo to Present in 44th Annual Raymond James Institutional Investors Conference
Mar 02, 2023 14:00pm

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 44th Annual Raymond James Institutional Investors on Tuesday, March 7, 2023 at 11:00 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide arr


Source:Business Wire
Masimo Corp. PT Raised to $195 at BTIG
Mar 01, 2023 10:43am

https://www.investing.com/news/pro/masimo-corp-pt-raised-to-195-at-btig-432SI-3018273


Source:Investing.com
Masimo Corporation 2022 Q4 - Results - Earnings Call Presentation
Feb 28, 2023 21:48pm

The following slide deck was published by Masimo Corporation in conjunction with their 2022 Q4 earnings call.


Source:Seeking Alpha
Masimo Non-GAAP EPS of $1.32 beats by $0.14, revenue of $617M beats by $14.51M
Feb 28, 2023 21:28pm

Masimo press release (MASI): Q4 Non-GAAP EPS of $1.32 beats by $0.14.Revenue of $617M (+88.4% Y/Y) beats by $14.51M.Full-Year 2022 Highlights:Consolidated revenue was…


Source:Seeking Alpha
Masimo Reports Fourth Quarter and Full-Year 2022 Financial Results
Feb 28, 2023 21:05pm

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 31, 2022. Fourth Quarter 2022 Results: Consolidated revenue was $617.0 million, representing 88.3% reported growth. Healthcare revenue was $351.9 million, representing 7.4% reported growth and 10.1% growth on a constant currency basis. Non-healthcare revenue was $265.1 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive


Source:Business Wire
Analyst Says This MedTech Giant Stock Offers ''Too Much Optionality,'' Upgrades Rating
Feb 22, 2023 18:15pm

Raymond James upgraded Masimo Corporation (NASDAQ: MASI ) from Market Perform To Outperform with a price target of $187 and says that no other company in its coverage offers as many paths to incremental value creation. The analyst writes that the stock setup seems attractive despite the uncomfortable headline P/E multiple. A vibrant pipeline adds new growth drivers and potential upside to year estimates. The analyst sees the 2H23 approval/launch of Stork (baby monitor) … Full story available on Benzinga.com


Source:Benzinga
Masimo raised to Outperform at Raymond James ahead of Q4 earnings
Feb 22, 2023 15:53pm

Raymond James upgraded Masimo Corporation (MASI) on Wednesday, expecting the MedTech company to beat Street forecasts when it issues Q4 financials next week. Read the full story here.


Source:Seeking Alpha
Apple Watch Risks US Import Ban After Biden Administration Upholds Patent Ruling
Feb 22, 2023 09:31am

The Biden administration has declined to overrule a U.S. International Trade Commission decision that the Apple Watch infringes patents from medical device company AliveCor, potentially paving the way for an import ban on Apple''s smartwatch depending on how the appeals process pans out. California-based AliveCor said in a statement that it was informed the Biden administration would not overrule a December decision from the ITC that found the Apple Watch infringed AliveCor health monitoring patents related to electrocardiogram technology. From AliveCor''s press release : "We applaud President Biden for upholding the ITC''s ruling and holding Apple accountable for infringing the patents that underpin our industry-leading ECG technology," said Priya Abani, CEO of AliveCor. "This decision goes beyond AliveCor and sends a clear message to innovators that the U.S. will protect patents to build and scale new technologies that benefit consumers." In the December ruling, the ITC recommended a limited exclusion order and a cease-and-desist order for Apple Watch models with ECG features.


Source:Mac Rumors
New Study Evaluates the Utility of Masimo ORi in Reducing Hyperoxemia During Laparoscopic Gastrectomy
Feb 21, 2023 07:00am

Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized controlled study published in Medicine in which Dr. Jin Hee Ahn and colleagues at the Sungkyunkwan University School of Medicine in Seoul, Korea, evaluated the ability of Masimo ORi to assist clinicians in guiding supplemental oxygenation during elective laparoscopic gastrectomy surgery. The researchers


Source:Wallstreet:Online
Top 5 4th Quarter Trades of 2Xideas AG
Feb 16, 2023 16:00pm

Related Stocks: ST , AVLR , HALO , LH , MASI ,


Source:GuruFocus
Masimo to Report Fourth Quarter and FY 2022 Financial Results After Market Close on Tuesday, February 28
Feb 14, 2023 14:00pm

Masimo (NASDAQ: MASI) will release fourth quarter and FY 2022 financial results for the period ended December 31, 2022, after the market closes on Tue


Source:Business Wire
Masimo reverses bylaws requiring detailed activist information
Feb 06, 2023 19:30pm

NEW YORK — U.S. medical device maker Masimo Corp changed its bylaws on Monday to stop requiring hedge funds to detail top secret data, ending, for now, a debate over how far corporate America will go to defend against agitating investors. The decision removes bylaw amendments adopted in September that required anyone nominating directors to […]


Source:Financial Post
Masimo backs off bylaw amendments requiring detailed information from activists
Feb 06, 2023 15:27pm

Medical device maker Masimo Corp on Monday said it changed its bylaws to eliminate requirements that would have forced investors seeking to nominate directors to the firm to reveal information that hedge funds consider to be top secret.


Source:Reuters
Hedge fund lobby group supports shareholder rights in Masimo case
Feb 03, 2023 02:30am

https://www.investing.com/news/stock-market-news/hedge-fund-lobby-group-supports-shareholder-rights-in-masimo-case-2994637


Source:Investing.com
Masimo Stock: Leveraging Its Sound United Acquisition (NASDAQ:MASI)
Feb 02, 2023 03:45am

In February, Masimo announced it''s acquisition of Sound United. Can MASI properly commercialize the opportunities? Click here to find out.


Source:Seeking Alpha
McGowan Allied Specialty Insurance Hires James as a Senior Producer
Feb 01, 2023 13:31pm

ST. PETERSBURG, Fla. , Feb. 1, 2023 /PRNewswire/ -- January 30, 2023 , McGowan Allied Specialty (MASI) Insurance hires Joe James as a Senior Producer. McGowan Allied Specialty Insurance (MASI), the premier provider of commercial insurance products to the amusement industry, has announced the hiring of Joe James as a Senior Producer. James brings 35 years of sales experience to McGowan Allied Specialty Insurance, with his last 23 in specialty sales for the Amusement Industry, offering risk analysis to prospects and clients with a keen focus on their unique needs. He worked directly with insureds to provide honest … Full story available on Benzinga.com


Source:Benzinga